Literature DB >> 8332669

The Dutch version of the Nottingham Health Profile: investigations of psychometric aspects.

R A Erdman1, J Passchier, M Kooijman, D L Stronks.   

Abstract

Data on the adaptation, reliability, and validity of the Dutch version of the Nottingham Health Profile are discussed. The linguistic adaptation of the English version into Dutch is described, followed by the field-testing procedure and the analyses of data from 276 selected subjects from an average general medical group practice in a village nearby Rotterdam. The internal consistency, Cronbach alphas, of the subscales varied from .70 to .85. Test-retest measures for 51 patients with cardiac problems gave Spearman correlations from .69 to .92, while the interscale relationships yielded six relatively independent areas of discomfort and stress. By means of logistic regression analysis on differences between old versus young, male versus female, and healthy versus ill individuals, discriminant validity was satisfactory. Findings suggest that the psychometric aspects of the Dutch version, also seen from a cross-cultural point of view, are sufficient. Nevertheless, further research on reliability and validity of the Dutch version is required to establish its usefulness with different patient groups.

Entities:  

Mesh:

Year:  1993        PMID: 8332669     DOI: 10.2466/pr0.1993.72.3.1027

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  15 in total

1.  The incidence and consequences of mental disturbances in elderly patients post cardiac surgery--a comparison with younger patients.

Authors:  J A Heijmeriks; W Dassen; K Prenger; H J Wellens
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

2.  Long term effects of intensity of upper and lower limb training after stroke: a randomised trial.

Authors:  G Kwakkel; B J Kollen; R C Wagenaar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

3.  Perceived health in a population based sample of victims of the 1956 polio epidemic in the Netherlands.

Authors:  F Nollet; B Ivanyi; A Beelen; R J De Haan; G J Lankhorst; M De Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  Daily spinal mechanical loading as a risk factor for acute non-specific low back pain: a case-control study using the 24-Hour Schedule.

Authors:  Eric W P Bakker; Arianne P Verhagen; Cees Lucas; Hans J C M F Koning; Rob J de Haan; Bart W Koes
Journal:  Eur Spine J       Date:  2006-04-29       Impact factor: 3.134

5.  Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia.

Authors:  R Arocho; C A McMillan; P Sutton-Wallace
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

6.  NHP or SIP--a comparative study in renal insufficiency associated anemia.

Authors:  M L Essink-Bot; P F Krabbe; H M van Agt; G J Bonsel
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

7.  The Nottingham Health Profile: score distribution, internal consistency and validity in asthma and COPD patients.

Authors:  M P Jans; F G Schellevis; J T van Eijk
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

8.  Quality of life bibliography and indexes: 1993 update.

Authors:  R A Berzon; G P Simeon; R L Simpson; M A Donnelly; H H Tilson
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

9.  Health-related quality of life among the least dependent institutional elderly compared with the non-institutional elderly population.

Authors:  A Noro; S Aro
Journal:  Qual Life Res       Date:  1996-06       Impact factor: 4.147

10.  Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial.

Authors:  Fieke S Koopman; Anita Beelen; Karin H Gerrits; Gijs Bleijenberg; Tineke A Abma; Marianne de Visser; Frans Nollet
Journal:  BMC Neurol       Date:  2010-01-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.